A Safety and Tolerability Study of ABT-126 in Elderly

• Status: Completed
• Trial end date: 1969-12-31
• Target enrollment: 0
• Participant gender: All

Summary

The objectives of this study are to assess the safety, tolerability and pharmacokinetics of ABT-126 in elderly subjects.

• Phase: Phase 1
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Abbott

Criteria

Inclusion Criteria:

• Healthy male or female subjects 65 years or greater.

• Has a MMSE score of 27 or higher.

Exclusion Criteria:

• History of dementia including by not limited to Alzheimer's disease, Parkinson's disease and mult-infarct dementia.

• History of any significant neurological disease.

• Has an estimated creatinine clearance < 30 mL/min